These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 9158680)

  • 1. Adrenocortical neoplasms: role of prognostic markers MIB-1, P53, and RB.
    Vargas MP; Vargas HI; Kleiner DE; Merino MJ
    Am J Surg Pathol; 1997 May; 21(5):556-62. PubMed ID: 9158680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of prognostic markers (MiB-1, RB, and bcl-2) in the diagnosis of parathyroid tumors.
    Vargas MP; Vargas HI; Kleiner DE; Merino MJ
    Mod Pathol; 1997 Jan; 10(1):12-7. PubMed ID: 9021722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of topoisomerase II alpha, MIB-1, p53, E-cadherin, retinoblastoma gene protein product, and HER-2/neu immunohistochemical expression for the prediction of biologic behavior in adrenocortical neoplasms.
    Gupta D; Shidham V; Holden J; Layfield L
    Appl Immunohistochem Mol Morphol; 2001 Sep; 9(3):215-21. PubMed ID: 11556748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of immunohistochemical expression of topoisomerase alpha II, MIB-1, p53, E-cadherin, retinoblastoma gene protein product, and HER-2/neu in adrenal and extra-adrenal pheochromocytomas.
    Gupta D; Shidham V; Holden J; Layfield L
    Appl Immunohistochem Mol Morphol; 2000 Dec; 8(4):267-74. PubMed ID: 11127918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 and Ki67 in adrenocortical tumors.
    Arola J; Salmenkivi K; Liu J; Kahri AI; Heikkilä P
    Endocr Res; 2000 Nov; 26(4):861-5. PubMed ID: 11196463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical assessment of proliferative activity in adrenocortical neoplasms.
    Goldblum JR; Shannon R; Kaldjian EP; Thiny M; Davenport R; Thompson N; Lloyd RV
    Mod Pathol; 1993 Nov; 6(6):663-8. PubMed ID: 7508113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoptosis control and proliferation marker in human normal and neoplastic adrenocortical tissues.
    Bernini GP; Moretti A; Viacava P; Bonadio AG; Iacconi P; Miccoli P; Salvetti A
    Br J Cancer; 2002 May; 86(10):1561-5. PubMed ID: 12085205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical features and immunoexpression of p53, MIB-1 and proliferating cell nuclear antigen in adrenal neoplasms.
    Martins AC; Cologna AJ; Tucci S; Suaid HJ; Falconi RA
    J Urol; 2005 Jun; 173(6):2138-42. PubMed ID: 15879867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of cell cycle inhibitor p27 and Ki-67 in human adrenocortical neoplasms.
    Nakazumi H; Sasano H; Iino K; Ohashi Y; Orikasa S
    Mod Pathol; 1998 Dec; 11(12):1165-70. PubMed ID: 9872646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical expression of bcl-2 and p53 oncoproteins: correlation with Ki67 proliferation index and prognostic histopathologic parameters in colorectal neoplasia.
    Saleh HA; Jackson H; Banerjee M
    Appl Immunohistochem Mol Morphol; 2000 Sep; 8(3):175-82. PubMed ID: 10981868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Weineke criteria, Ki-67 index and p53 status to study pediatric adrenocortical tumors: Is there a correlation?
    Das S; Sengupta M; Islam N; Roy P; Datta C; Mishra PK; Banerjee S; Chaudhuri MK; Chatterjee U
    J Pediatr Surg; 2016 Nov; 51(11):1795-1800. PubMed ID: 27567308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bcl-2, p53 and MIB-1 expression in normal and neoplastic parathyroid tissues.
    Naccarato AG; Marcocci C; Miccoli P; Bonadio AG; Cianferotti L; Vignali E; Cipollini G; Viacava P
    J Endocrinol Invest; 1998 Mar; 21(3):136-41. PubMed ID: 9591207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-myc expression in adrenocortical tumours.
    Pennanen M; Hagström J; Heiskanen I; Sane T; Mustonen H; Arola J; Haglund C
    J Clin Pathol; 2018 Feb; 71(2):129-134. PubMed ID: 28801349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proliferative activity and genetic changes in adrenal cortical tumors examined by flow cytometry, fluorescence in situ hybridization and immunohistochemistry.
    Takehara K; Sakai H; Shono T; Irie J; Kanetake H
    Int J Urol; 2005 Feb; 12(2):121-7. PubMed ID: 15733104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IGFII and MIB1 immunohistochemistry is helpful for the differentiation of benign from malignant adrenocortical tumours.
    Schmitt A; Saremaslani P; Schmid S; Rousson V; Montani M; Schmid DM; Heitz PU; Komminoth P; Perren A
    Histopathology; 2006 Sep; 49(3):298-307. PubMed ID: 16918977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic and prognostic features in adrenocortical carcinoma: a single institution case series and review of the literature.
    Wanis KN; Kanthan R
    World J Surg Oncol; 2015 Mar; 13():117. PubMed ID: 25889798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered patterns of retinoblastoma gene product expression in benign, premalignant and malignant epithelium of the larynx: an immunohistochemical study including correlation with p53, bcl-2 and proliferating indices.
    Ioachim E; Assimakopoulos D; Agnantis NJ; Peschos D; Zissi A; Skevas A
    Anticancer Res; 1999; 19(1A):541-5. PubMed ID: 10226595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discerning malignancy in adrenocortical tumors: are molecular markers useful?
    Wachenfeld C; Beuschlein F; Zwermann O; Mora P; Fassnacht M; Allolio B; Reincke M
    Eur J Endocrinol; 2001 Sep; 145(3):335-41. PubMed ID: 11517015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathobiology of pituitary adenomas and carcinomas.
    Scheithauer BW; Gaffey TA; Lloyd RV; Sebo TJ; Kovacs KT; Horvath E; Yapicier O; Young WF; Meyer FB; Kuroki T; Riehle DL; Laws ER
    Neurosurgery; 2006 Aug; 59(2):341-53; discussion 341-53. PubMed ID: 16883174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 expression in pituitary adenomas and carcinomas: correlation with invasiveness and tumor growth fractions.
    Thapar K; Scheithauer BW; Kovacs K; Pernicone PJ; Laws ER
    Neurosurgery; 1996 Apr; 38(4):765-70; discussion 770-1. PubMed ID: 8692397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.